Molecular Biometrics Closes $12.5 Million Series B Equity Funding
1/12/2010 6:55:28 AM
More...
|
Molecular Biometrics: New Studies Demonstrate Accuracy Of Novel, Metabolomic Profiling Technology In Predicting Viability Of Frozen And Advanced Stage Embryos
6/30/2009 1:34:33 PM
More...
|
Safeguard Scientifics (SFE) and Oxford Bioscience Partners Co-Lead $12 Million Series a Financing for Molecular Biometrics
11/10/2008 7:24:28 AM
More...
|
Molecular Biometrics Announces Results of Parkinson's Disease Research and Receipt of Grant From The Michael J. Fox Foundation to Advance Diagnostic Technology
8/6/2008 1:47:46 PM
More...
|
Molecular Biometrics Release: Embryo Viability Studies Support Utility of Novel, Metabolomic Profiling Technology
7/7/2008 11:29:56 AM
More...
|
Molecular Biometrics Hires New Chief Scientific Officer; Opening U.S. Research Facility
1/23/2008 8:48:18 AM
More...
|
Molecular Biometrics Release: Metabolomic Profiling Accurately Identifies Stages of Oocyte Maturation in IVF
10/16/2007 8:32:02 AM
More...
|
Molecular Biometrics to Provide Update on Its Metabolomics Platform and Lead Product for Non-Invasive Embryo Viability Testing in IVF
9/6/2007 9:23:54 AM
More...
|
Molecular Biometrics Researchers to Report Progress Using Metabolomic Profiling of Biomarkers as Assisted Reproductive Procedure in Assessing Embryo Viability for In Vitro Fertilization
6/28/2007 10:26:40 AM
More...
|
Molecular Biometrics Identifies Promising Biomarkers for Diagnosis of Parkinson's Disease
5/3/2007 1:55:44 PM
More...
|
|